Persistent Intraocular Residue with the Use of Dexycu® in Cataract Extraction: A Case Series
Ryan T. Wallace
John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
Annika M. Hansen
School of Medicine, University of Utah, Salt Lake City, UT, USA.
John A. Musser VI
John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
Anthony P. Mai
John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
Craig J. Chaya *
John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
*Author to whom correspondence should be addressed.
Abstract
Purpose: The objective of this article is to report 8 cases of persistent IOL residue associated with the use of Dexycu® in the context of cataract surgery and then to subsequently describe each patients clinical course.
Observations and Presentation: Between 2020-2021, persistent residue was noted in 8 eyes of 7 patients who received Dexycu® implants after cataract surgery. The residue was identified an average of 1.63 months after surgery (range 0.20-4.23). A subsequent procedure removed the residue from the intraocular lens; the average time to the follow-up procedure after surgery was 4.71 months (range 1.90-11.20).
Conclusions and Importance: The Bausch and Lomb intraocular lenses seem to be predisposed to a Dexycu® persistent opacification, however correlation does not equate with causation. This article documents cases of persistent IOL residue with the use of Dexycu® and the MX60 lenses and its toric varieties. Further evaluation is necessary to elucidate the mechanism and risk factors for this occurrence.
Keywords: Cataract surgery, Dexycu, residue polish, tano diamond brush